The surgical management of ovarian cancer

Cancer Treatment Reviews

Volumn 27, Issue 2, 2001, Pages 111-118

  Stratton, J F ^a   Tidy, J A ^a   Paterson, M E L ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Ovarian cancer; Surgical management

Indexed keywords

ABDOMINAL HYSTERECTOMY; ASCITES; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CURETTAGE; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; GRANULOSA CELL TUMOR; HUMAN; LAPAROSCOPY; LAPAROTOMY; LYMPHADENECTOMY; OVARY CANCER; PRACTICE GUIDELINE; REVIEW; SALPINGOOOPHORECTOMY; SALVAGE THERAPY; SECOND LOOK SURGERY; SERTOLI CELL TUMOR; SURGICAL TECHNIQUE;

EID: 0034991174     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0196     Document Type: Review

References (82)

1. The impact of subspecialty training on the management of advanced ovarian cancer
2. National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival
3. Specialist gynaecologists and survival outcomes in ovarian cancer. A Scottish National Study of 1866 patients
4. Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer
5. Is routine appendectomy beneficial in the management of ovarian cancer?
6. Appendectomy in the surgical staging of ovarian carcinoma
7. Appendectomy and carcinoma ovarii. Cytoreduction, palliation, or simple tradition?
8. Role of appendectomy in the surgical management of ovarian cancer
9. The role of appendectomy in surgical procedures for ovarian cancer
10. Appendectomy in primary and secondary staging operations for ovarian malignancy
11. Management and prognosis of adenocarcinoma of the appendix
12. Adenocarcinoid of the appendix presenting as bilateral Krukenberg's tumor of the ovaries. Immunohistochemical and ultrastructural studies and literature review
13. Goblet cell carcinoid of the vermiform appendix with ovarian metastasis mimicking mucinous cystadenocarcinoma
14. Appendiceal carcinoma metastatic to the ovaries and mimicking primary ovarian tumors
15. Krukenberg tumor of the ovary from an occult appendiceal primary: Case report and literature review
16. Mucinous tumours of the appendix associated with mucinous tumours of the ovary and pseudomyxoma peritonei: A clinicopathological analysis of 22 cases
17. Pseudomyxoma peritonei: A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumours
18. Pseudomyxoma peritonei. New concepts in management with a report of seventeen patients
19. Pseudomyxoma peritonei et ovarii associated with sequential ovarian and appendicular tumors and acromegaly
20. Pseudomyxoma peritonei: A review of 23 cases
21. Epithelial ovarian cancer: Impact of surgery and chemotherapy on survival during 1977-1990
22. Adjuvant therapy in stage I and stage II epithelial ovarian cancer: Results of two prospective randomized trials
23. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma
24. Laparotomy to complete staging of presumed early ovarian cancer
25. Surgical staging of carcinoma of the ovaries
26. Role of cytoreductive surgeral treatment in the management of advanced ovarian cancer
27. Primary cytoreductive surgery for epithelial ovarian cancer
28. Meta-analysis of surgery in advanced ovarian carcinoma, is maximum cytoreductive surgery an independent determinant on prognosis?
29. The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery
30. Neoadjuvant chemotherapy for advanced ovarian cancer
31. Stage III epithelial ovarian cancer: The role of maximal surgical reduction
32. Primary surgical therapy of ovarian cancer: How much and when
33. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
34. Interval debulking of ovarian cancer - An interim measure
35. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced unresected epithelial ovarian cancer
36. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced ovarian cancer
37. Early second surgery in ovarian cancer-improving the potential for cure or another unnecessary operation?
38. Intervention debulking surgery in advanced epithelial ovarian cancer
39. Treatment of advanced epithelial ovarian cancer with cisplatin and cisplatin and cyclophosphamide
40. Primary or delayed debulking surgery and chemotherapy of cisplatin, doxorubicin and cyclophosphamide in stage III-IV epithelial ovarian carcinoma
41. Survival of patients following secondary cytoreductive surgery in ovarian cancer
42. Second look laparotomy in stage III epithelial ovarian cancer: Clinical variables associated with disease status
43. Surgery for advanced ovarian cancer
44. Second look laparotomy and salvage therapy: A research modality only?
45. Second-look operation in ovarian cancer
46. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer
47. Radical surgery procedure improves survival time in patients with recurrent ovarian cancer
48. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response
49. Lymphadenectomy in stage 1 ovarian cancer
50. Lymph node metastases of ovarian cancer. A preliminary survey of 74 cases of lymphadenectomy
51. Randomised study comparing systematic pelvic (PE) and aotic (A) lymphadenectomy in early ovarian carcinoma or at second look surgery versus no lymphadenectomy: Feasibility and complications
52. Selective pelvic and para-aortic lymphadenectomy
53. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer
54. Pelvic lymphadenectomy in operative treatment of ovarian cancer
55. Pelvic and paraaortic lymphadenectomy in cancer of the ovary
56. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to stage I/II patients and superior survival to other stage III patients
57. Evaluation of cytoreductive surgery with lymphadenectomy including para-aortic nodes for advanced ovarian cancer
58. Pelvic and paraortic lymph nodal status in advanced ovarian cancer and survival
59. Staging laparatomy in early ovarian carcinoma
60. Conservative surgery for stage I ovarian carcinoma in women of childbearing age
61. Initial therapy for early ovarian carcinoma
62. The treatment of early stage ovarian cancer
63. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma
64. Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging
65. Prognostic factors in patients with stage I epithelial ovarian cancer
66. Prognostic factors for survival in stage I epithelial ovarian carcinoma
67. Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five year cancer registry review
68. Laparoscopic infrarenal node dissection for restaging of carcinomas of the ovary or fallopian tube
69. Tumor implantation after diagnostic laparoscopic biopsy of serous ovarian tumors of low malignant potential
70. A comparison of ovarian cyst aspirate cytology and histology. The case against aspiration of cystic pelvic masses
71. American Association of Gynecologic Laparoscopists 1998 membership survey on operative laparoscopy
72. Management of ovarian masses: AAGL 1990 survey
73. Laparoscopic removal of dermoid cysts
74. Laparoscopic diagnosis of adnexal cystic masses: A 12 year experience with long term follow-up
75. Pseudomixoma peritonei, a review
76. Intestinal obstruction in patients with ovarian cancer: Variables associated with surgical complications and survival
77. Percutaneous endoscopic gastrotomy for decompression in metastatic gynecologic malignancies
78. Immature (malignant) teratoma of the ovary
79. Clinicopathological review of 118 granulosa cell tumour and 82 theca cell tumours
80. Carcinosarcoma of the ovary treated over a ten year period at the Christie Hospital
81. Guidelines for surgical staging of ovarian cancer
82. Revised FIGO staging for gynaecological cancer